Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First-trimester Placental Ultrasound Study (First PLUS): an Observational Cohort Study to Assess the Clinical Utility of the OxNNet Toolkit for the Prediction of Adverse Pregnancy Outcomes.

NCT05326191 is registered in ClinicalTrials.gov with Perspectum as lead sponsor.

NCT NCT05326191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05326191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First-trimester Placental Ultrasound Study (First PLUS): an Observational Cohort Study to Assess the Clinical Utility of the OxNNet Toolkit for the Prediction of Adverse Pregnancy Outcomes.
Lead sponsor
Perspectum
Phase
Observational
Overall status
Completed
Start date
March 15, 2022
Completion date
May 30, 2023
Enrollment
4,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fetal growth complications, pregnancy complications